Exclusive

Publication

Byline

Location

US Patent Issued to Paragon Therapeutics on Aug. 11 for "Method of treating inflammatory bowel disease" (Puerto Rico, New Hampshire, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,749, issued on Aug. 11, was assigned to Paragon Therapeutics Inc. (Waltham, Mass.). "Method of treating inflammatory bowel disease" was inv... Read More


US Patent Issued to Northwestern University on Aug. 11 for "Humanized antibody targeting the tumor associated antigen IL13Ra2" (Illinois Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,750, issued on Aug. 11, was assigned to Northwestern University (Evanston, Ill.). "Humanized antibody targeting the tumor associated antige... Read More


US Patent Issued to INTERVET on Aug. 11 for "Caninized rat antibodies to canine interleukin-31 receptor alpha" (California, Nebraska, New Jersey Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,751, issued on Aug. 11, was assigned to INTERVET INC. (Rahway, N.J.). "Caninized rat antibodies to canine interleukin-31 receptor alpha" wa... Read More


US Patent Issued to CILAG GMBH INTERNATIONAL on Aug. 11 for "Multispecific antibodies having specificity for IL-4R and IL-31, encoding nucleic acids thereof and methods of treating" (Swiss, Japanese, French Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,752, issued on Aug. 11, was assigned to CILAG GMBH INTERNATIONAL (Zug, Switzerland). "Multispecific antibodies having specificity for IL-4R... Read More


US Patent Issued to Elanco US on Aug. 11 for "NGF antagonists for medical use" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,753, issued on Aug. 11, was assigned to Elanco US Inc. (Greenfield, Ind.). "NGF antagonists for medical use" was invented by Hangjun Zhan (... Read More


US Patent Issued to KYMAB on Aug. 11 for "Treatment of atopic dermatitis" (French, British Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,754, issued on Aug. 11, was assigned to KYMAB Ltd. (Cambridge, Great Britain). "Treatment of atopic dermatitis" was invented by Ben Porter-... Read More


US Patent Issued to HARBOUR BIOMED (SUZHOU) on Aug. 11 for "Antibody targeting BCMA, bispecific antibody, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,755, issued on Aug. 11, was assigned to HARBOUR BIOMED (SUZHOU) Co. LTD. (Suzhou, China). "Antibody targeting BCMA, bispecific antibody, an... Read More


US Patent Issued to CUROCELL, EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION on Aug. 11 for "BCMA-specific antibody and chimeric antigen receptor" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,756, issued on Aug. 11, was assigned to CUROCELL INC. (Daejeon, South Korea) and EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (Seoul, S... Read More


US Patent Issued to City of Hope on Aug. 11 for "Anti-HVEM antibodies" (American, Taiwanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,757, issued on Aug. 11, was assigned to City of Hope (Duarte, Calif.). "Anti-HVEM antibodies" was invented by Flavia Pichiorri (La Canada, ... Read More


US Patent Issued to CHANGQING GENRIX BIOPHARMACEUTICAL on Aug. 11 for "Anti-CD3E/BCMA bispecific antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,758, issued on Aug. 11, was assigned to CHANGQING GENRIX BIOPHARMACEUTICAL Co. LTD. (Chongqing, China). "Anti-CD3E/BCMA bispecific antibody... Read More